Mindray Medical International (MR) versus Biolase (BIOL) Critical Survey
Biolase (NASDAQ: BIOL) and Mindray Medical International (NYSE:MR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability.
This table compares Biolase and Mindray Medical International’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Mindray Medical International||15.93%||12.70%||8.37%|
This is a breakdown of recent ratings for Biolase and Mindray Medical International, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Mindray Medical International||0||0||0||0||N/A|
Biolase currently has a consensus price target of $2.50, suggesting a potential upside of 495.24%. Given Biolase’s higher possible upside, analysts clearly believe Biolase is more favorable than Mindray Medical International.
Institutional & Insider Ownership
38.9% of Biolase shares are owned by institutional investors. 7.1% of Biolase shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Biolase does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.
Earnings & Valuation
This table compares Biolase and Mindray Medical International’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Biolase||$51.81 million||0.62||-$15.37 million||($0.31)||-1.35|
|Mindray Medical International||N/A||N/A||N/A||$1.49||18.75|
Mindray Medical International has lower revenue, but higher earnings than Biolase. Biolase is trading at a lower price-to-earnings ratio than Mindray Medical International, indicating that it is currently the more affordable of the two stocks.
Biolase beats Mindray Medical International on 6 of the 11 factors compared between the two stocks.
BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
About Mindray Medical International
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Receive News & Ratings for Biolase Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biolase and related companies with MarketBeat.com's FREE daily email newsletter.